Ledger.Open graph →
SEC Form D · filed July 23, 2014

LQ3 Pharmaceuticals, Inc

Offering
$10.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MORRISVILLE, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Gerald J. Cardinale · New York, NYDirectorDr. Robert L. Mercer · New York, NYDirectorMark F. Silber · New York, NYDirectorJames S. Rowen · New York, NYExec · DirectorDr. Peter F. Brown · New York, NYExecNorman P. Leenhouts · Rochester, NYExec · Director · PromoterChristopher L. Czarnecki · Rochester, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗